Amgen (AMGN) Earnings: Results, Guidance and Stock Reaction
Amgen's latest report was Q3 2026 on November 3, 2026 (after the close): Beat, shrugged, and the stock moved -1.6% on it. Below: the numbers vs Wall Street, then every quarter we've explained in plain English.
Latest: Q3 2026 vs consensus
| Metric | Reported | Consensus | Result |
|---|---|---|---|
| Adjusted EPS | $6.45 (up 14% y/y) | $5.76 (Investing.com) | Beat |
| Revenue | $10.37B (up 8% y/y) | $10.06B (Investing.com) | Beat |
| FY2026 revenue guidance | $38.9-$39.7B | $39.0B (Investing.com) | Midpoint above |
| FY2026 adj. EPS guidance | $22.90-$23.70 | $23.02 (Investing.com) | Midpoint above |
Full AMGN Q3 2026 explainer: what mattered, the reaction and Max's verdict →
Every Amgen report we've explained
- Q3 2026 (November 3, 2026, after the close): Beat, shrugged · stock -1.6% after
Get the next AMGN report explained in your inbox.
Every big earnings report in plain English: beat or miss, guidance, and how the stock took it. No spam, unsubscribe anytime.
FAQ
Did Amgen (AMGN) beat earnings last quarter?
In Q3 2026, reported November 3, 2026, Amgen came in Beat, shrugged. Adjusted EPS: $6.45 (up 14% y/y) vs $5.76 (Investing.com); Revenue: $10.37B (up 8% y/y) vs $10.06B (Investing.com); FY2026 revenue guidance: $38.9-$39.7B vs $39.0B (Investing.com).
When did Amgen last report earnings?
Amgen reported Q3 2026 results on November 3, 2026, after the close.
Get tomorrow's five at 7 AM, free.
Max Edge's Bold Bet of the Day plus every pick graded in public, before the opening bell.